Miran Kim, PhD

Miran Kim, PhD, is a tumor cell biologist and assistant professor in the Department of Internal Medicine, Rush University Medical Center.  She received a PhD in Life Science from KAIST in South Korea and trained at the Salk Institute in San Diego, California of Sheffield in UK as a postdoctoral research fellow.  Her research has been focused on the molecular and cellular mechanisms of liver cancer for over 15 years.  Over a decade of her work at Brown School/Rhode Island Hospital broadened the knowledge of T-cell factor-4 (TC-4) splicing isoforms in hepatocellular carcinoma (HCC) and found evidence that only a certain subset of these proteins contributed to hepatocyte transformation and malignant phenotype.  Her current research interests include the relationship between loco-regional therapy and TCF-4 in HCC; tumor microenvironment and tumor-associated immune cells.